p21(WAF1/CIP1) expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations

Giuseppe Viale, Caterina Pellegrini, Giovanni Mazzarol, Patrick Maisonneuve, Mark L. Silverman, Silvano Bosari

Research output: Contribution to journalArticle

Abstract

Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21(WAF1/CIP1) is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21(WAF1/CIP1) expression has been investigated immunohistochemically in a series of 191 patients with colorectal cancer of known p53 status. The purpose of the study was two-fold: to assess the relationship between p21(WAF1/CIP1) immunoreactivity and p53 alterations, and to evaluate the prognostic significance of p21(WAF1/CIP1) expression. In 96 carcinomas (51 per cent), p21(WAF1/CIP1) was expressed in over 10 per cent of tumour cells, whereas in 26, p21(WAF1/CIP1) was detected in under 10 per cent of neoplastic cells; 69 tumours lacked p21(WAF1/CIP1) expression. Immunoreactivity was more frequent in tumours of the right colon (p

Original languageEnglish
Pages (from-to)302-307
Number of pages6
JournalJournal of Pathology
Volume187
Issue number3
DOIs
Publication statusPublished - 1999

Fingerprint

Colorectal Neoplasms
Mutation
Neoplasms
Cell Cycle
Cyclin-Dependent Kinases
Colon
Carcinoma

Keywords

  • Colorectal carcinoma
  • Immunohistochemistry
  • p21(WAF1/CIP1)
  • p53
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

p21(WAF1/CIP1) expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. / Viale, Giuseppe; Pellegrini, Caterina; Mazzarol, Giovanni; Maisonneuve, Patrick; Silverman, Mark L.; Bosari, Silvano.

In: Journal of Pathology, Vol. 187, No. 3, 1999, p. 302-307.

Research output: Contribution to journalArticle

@article{ba0dcc94bfca4b56a52a25fb0169177c,
title = "p21(WAF1/CIP1) expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations",
abstract = "Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21(WAF1/CIP1) is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21(WAF1/CIP1) expression has been investigated immunohistochemically in a series of 191 patients with colorectal cancer of known p53 status. The purpose of the study was two-fold: to assess the relationship between p21(WAF1/CIP1) immunoreactivity and p53 alterations, and to evaluate the prognostic significance of p21(WAF1/CIP1) expression. In 96 carcinomas (51 per cent), p21(WAF1/CIP1) was expressed in over 10 per cent of tumour cells, whereas in 26, p21(WAF1/CIP1) was detected in under 10 per cent of neoplastic cells; 69 tumours lacked p21(WAF1/CIP1) expression. Immunoreactivity was more frequent in tumours of the right colon (p",
keywords = "Colorectal carcinoma, Immunohistochemistry, p21(WAF1/CIP1), p53, Prognosis",
author = "Giuseppe Viale and Caterina Pellegrini and Giovanni Mazzarol and Patrick Maisonneuve and Silverman, {Mark L.} and Silvano Bosari",
year = "1999",
doi = "10.1002/(SICI)1096-9896(199902)187:3<302::AID-PATH243>3.0.CO;2-U",
language = "English",
volume = "187",
pages = "302--307",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - p21(WAF1/CIP1) expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations

AU - Viale, Giuseppe

AU - Pellegrini, Caterina

AU - Mazzarol, Giovanni

AU - Maisonneuve, Patrick

AU - Silverman, Mark L.

AU - Bosari, Silvano

PY - 1999

Y1 - 1999

N2 - Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21(WAF1/CIP1) is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21(WAF1/CIP1) expression has been investigated immunohistochemically in a series of 191 patients with colorectal cancer of known p53 status. The purpose of the study was two-fold: to assess the relationship between p21(WAF1/CIP1) immunoreactivity and p53 alterations, and to evaluate the prognostic significance of p21(WAF1/CIP1) expression. In 96 carcinomas (51 per cent), p21(WAF1/CIP1) was expressed in over 10 per cent of tumour cells, whereas in 26, p21(WAF1/CIP1) was detected in under 10 per cent of neoplastic cells; 69 tumours lacked p21(WAF1/CIP1) expression. Immunoreactivity was more frequent in tumours of the right colon (p

AB - Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21(WAF1/CIP1) is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21(WAF1/CIP1) expression has been investigated immunohistochemically in a series of 191 patients with colorectal cancer of known p53 status. The purpose of the study was two-fold: to assess the relationship between p21(WAF1/CIP1) immunoreactivity and p53 alterations, and to evaluate the prognostic significance of p21(WAF1/CIP1) expression. In 96 carcinomas (51 per cent), p21(WAF1/CIP1) was expressed in over 10 per cent of tumour cells, whereas in 26, p21(WAF1/CIP1) was detected in under 10 per cent of neoplastic cells; 69 tumours lacked p21(WAF1/CIP1) expression. Immunoreactivity was more frequent in tumours of the right colon (p

KW - Colorectal carcinoma

KW - Immunohistochemistry

KW - p21(WAF1/CIP1)

KW - p53

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0032587519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032587519&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199902)187:3<302::AID-PATH243>3.0.CO;2-U

DO - 10.1002/(SICI)1096-9896(199902)187:3<302::AID-PATH243>3.0.CO;2-U

M3 - Article

C2 - 10398083

AN - SCOPUS:0032587519

VL - 187

SP - 302

EP - 307

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -